Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AUTOMATIC DATA PROCESSING INCADP · Entity 1584 | Director | November 12, 2025 | November 14, 2025 |
| CVS HEALTH CorpCVS · Entity 2884 | Director · President and CEO | April 01, 2024 | April 03, 2024 |
| THERMO FISHER SCIENTIFIC INC.TMO · Entity 2836 | Director | September 26, 2026 | September 29, 2026 |
| US BANCORP DEUSB · Entity 2923 | Director | December 17, 2021 | December 20, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AUTOMATIC DATA PROCESSING INC
Report date November 12, 2025 · Filed November 14, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,535 |
Reported balance
After 2025-11-12 transaction · row 1
1 source rowRow 1 · 2025-11-12 · Grant · Acquired 1,453 · Balance 1,535 |
CVS HEALTH Corp
Report date April 01, 2024 · Filed April 03, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock (Restricted)SEC Table I · non-derivative | Direct | 45,248 |
Reported balance
After 2024-04-01 transaction · row 1
1 source rowRow 1 · 2024-04-01 · Grant · Acquired 45,248 · Balance 45,248 F1: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal annual installments, commencing 4/1/2025. |
| Common StockSEC Table I · non-derivative | Direct | 74,687 |
Reported balance
After 2024-04-01 transaction · row 2
1 source rowRow 2 · 2024-04-01 · Tax withholding · Disposed 61,953 · Balance 74,687 F2: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of performance stock units. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $79.56 · Expires 2034-04-01 | Direct | 188,087 |
Reported balance
After 2024-04-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-04-01 · Grant · Acquired 188,087 · Balance 188,087 F3: Option becomes exercisable in four equal annual installments, commencing 4/1/2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in four equal annual installments, commencing 4/1/2025.
F2: Surrender of shares in payment of withholding taxes due upon the vesting and settlement of performance stock units.
F3: Option becomes exercisable in four equal annual installments, commencing 4/1/2025.
THERMO FISHER SCIENTIFIC INC.
Report date September 26, 2026 · Filed September 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom Stock UnitsSEC Table II · derivative / convertible security | Direct | 398.7 |
Reported balance
After 2026-09-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-26 · Grant · Acquired 46.3 · Balance 398.7 F1: Convertible into Common Stock on a 1-for-1 basis. F2: Represents stock units credited to the Reporting Person's account as of September 26, 2026, at a price of $675.00 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control. |
Filing footnotes · ownership attribution and instrument terms
F1: Convertible into Common Stock on a 1-for-1 basis.
F2: Represents stock units credited to the Reporting Person's account as of September 26, 2026, at a price of $675.00 per unit pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). Directors' retainers are deferred quarterly under the Plan as Common Stock units based on the closing price of the stock as of the quarter end. The shares are distributable as stock upon cessation of director service (for any reason) or a change of control.
US BANCORP DE
Report date December 17, 2021 · Filed December 20, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Compensation Plan ParticipationSEC Table II · derivative / convertible security | Direct | 7,796 |
Reported balance
After 2021-12-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-12-17 · Grant · Acquired 13 · Balance 7,796 F1: Deferred Compensation Plan Participation is payable in common stock when the reporting person ceases to serve on U.S. Bancorp's Board of Directors. F2: Includes amounts acquired pursuant to dividend reinvestment. |
Filing footnotes · ownership attribution and instrument terms
F1: Deferred Compensation Plan Participation is payable in common stock when the reporting person ceases to serve on U.S. Bancorp's Board of Directors.
F2: Includes amounts acquired pursuant to dividend reinvestment.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AETNA INC /PA/
Report date November 28, 2018 · Filed November 28, 2018
Section 16 reporting ended · disclosed 2018-11-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 1
1 source rowRow 1 · 2018-11-28 · Disposition to issuer · Disposed 74,896 · Balance 0 F1: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. |
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $100.50 | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2018-11-28 · Disposition to issuer · Disposed 110,209 · Balance 0 F2: Represents Stock Appreciation Rights ("SARs") granted under the Aetna Inc. 2010 Stock Incentive Plan (the "Plan") on March 2, 2015. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date, less (c) the exercise price (the "SAR Amount"). |
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $103.45 | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2018-11-28 · Disposition to issuer · Disposed 103,323 · Balance 0 F3: Represents SARs granted under the Plan on February 19, 2016, of which 66.7% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement. |
| Stock Appreciation RightsSEC Table II · derivative / convertible security · Conversion / exercise price $125.27 | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-11-28 · Disposition to issuer · Disposed 105,941 · Balance 0 F4: Represents SARs granted under the Plan on February 17, 2017, of which 33.3% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-11-28 · Disposition to issuer · Disposed 29,580 · Balance 0 F5: Represents Performance Stock Units ("PSUs") earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 19, 2016. These PSUs were converted to time-vesting CVS Health Restricted Stock Units ("RSUs") pursuant to the terms of the Merger Agreement. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2018-11-28 · Disposition to issuer · Disposed 13,172 · Balance 0 F6: PSUs earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 17, 2017. These PSUs were converted to time-vesting CVS Health RSUs pursuant to the terms of the Merger Agreement. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2018-11-28 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2018-11-28 · Disposition to issuer · Disposed 30,981 · Balance 0 F7: RSUs granted under the Plan on March 2, 2018. These RSUs were converted to CVS Health RSUs pursuant to the terms of the Merger Agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock.
F2: Represents Stock Appreciation Rights ("SARs") granted under the Aetna Inc. 2010 Stock Incentive Plan (the "Plan") on March 2, 2015. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date, less (c) the exercise price (the "SAR Amount").
F3: Represents SARs granted under the Plan on February 19, 2016, of which 66.7% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement.
F4: Represents SARs granted under the Plan on February 17, 2017, of which 33.3% had vested. Each vested SAR was canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash equal to the SAR Amount. Each unvested SAR was converted to a CVS Health SAR pursuant to the terms of the Merger Agreement.
F5: Represents Performance Stock Units ("PSUs") earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 19, 2016. These PSUs were converted to time-vesting CVS Health Restricted Stock Units ("RSUs") pursuant to the terms of the Merger Agreement.
F6: PSUs earned at a specified level in conjunction with the change in control of Aetna and pursuant to the terms of the relevant PSU award agreement. The PSUs were originally granted under the Plan on February 17, 2017. These PSUs were converted to time-vesting CVS Health RSUs pursuant to the terms of the Merger Agreement.
F7: RSUs granted under the Plan on March 2, 2018. These RSUs were converted to CVS Health RSUs pursuant to the terms of the Merger Agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 28, 2018 Filed Nov 28, 2018 16:21 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerStock Appreciation Rights · Derivative | 110,209 | Not disclosed Strike: $100.50 | Not disclosed |
DisclosureSEC source: 0001122304-18-000162 · edgar.xml · derivative · entry 2 Lynch Karen S · CIK 0001333760 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 110,209 shares Expires not disclosed F2 · price: Represents Stock Appreciation Rights ("SARs") granted under the Aetna Inc. 2010 Stock Incentive Plan (the "Plan") on March 2, 2015. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date, less (c) the exercise price (the "SAR Amount"). F2 · derivative.exercise_date: Represents Stock Appreciation Rights ("SARs") granted under the Aetna Inc. 2010 Stock Incentive Plan (the "Plan") on March 2, 2015. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date, less (c) the exercise price (the "SAR Amount"). F2 · derivative.expiration_date: Represents Stock Appreciation Rights ("SARs") granted under the Aetna Inc. 2010 Stock Incentive Plan (the "Plan") on March 2, 2015. These SARs were canceled pursuant to the terms of the Merger Agreement in exchange for an amount in cash for each SAR equal to (a) $145 plus (b) 0.8378 multiplied by the average of the volume weighted averages of the trading prices of CVS Health Common Stock on each of the five consecutive trading days ending on the trading day two trading days prior to the closing date, less (c) the exercise price (the "SAR Amount"). Read SEC document |
| November 28, 2018 Filed Nov 28, 2018 16:21 UTC | AETNA INC /PA/ AET · Entity 107289 | Disposition to issuerCommon Stock | 74,896 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-18-000162 · edgar.xml · nonDerivative · entry 1 Lynch Karen S · CIK 0001333760 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Converted pursuant to the merger agreement (the "Merger Agreement") between CVS Health Corporation ("CVS Health") and Aetna Inc. ("Aetna") into $145 in cash and 0.8378 shares of CVS Health Common Stock for each share of Aetna Common Stock. Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:05 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Appreciation Rights · Derivative | 93,989 | $37.91 Strike: $37.91 | $3,563,122.99 |
DisclosureSEC source: 0001127602-18-034855 · form4.xml · derivative · entry 5 Lynch Karen S · CIK 0001333760 · EVP & Pres, Aetna Bus Unit 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,989 Underlying: Common Stock · 93,989 shares Expires 2026-02-18 F5 · derivative.exercise_date: Represents unvested Stock Appreciation Rights ("SARs") granted under the Plan on February 19, 2016 that were converted into CVS Health SARs pursuant to the terms of the Merger Agreement. These SARs vest on February 19, 2019. Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:05 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Appreciation Rights · Derivative | 192,741 | $45.91 Strike: $45.91 | $8,848,739.31 |
DisclosureSEC source: 0001127602-18-034855 · form4.xml · derivative · entry 4 Lynch Karen S · CIK 0001333760 · EVP & Pres, Aetna Bus Unit 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 192,741 Underlying: Common Stock · 192,741 shares Expires 2027-02-16 F4 · derivative.exercise_date: Represents unvested Stock Appreciation Rights ("SARs") granted under the Plan on February 17, 2017 that were converted into CVS Health SARs pursuant to the terms of the Merger Agreement. These SARs vest in two substantally equal annual installments beginning on February 17, 2019. Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:05 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 31,144 | $80.27 | $2,499,928.88 |
DisclosureSEC source: 0001127602-18-034855 · form4.xml · nonDerivative · entry 3 Lynch Karen S · CIK 0001333760 · EVP & Pres, Aetna Bus Unit 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,359 F3 · shares: Consists of CVS RSUs awarded pursuant to the Plan. Restrictions lapse on 11/28/2021. Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:05 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 201,215 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-034855 · form4.xml · nonDerivative · entry 2 Lynch Karen S · CIK 0001333760 · EVP & Pres, Aetna Bus Unit 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,215 F2 · price: Includes (1) 80,722 CVS Health Restricted Stock Units ("RSUs") that were converted from Aetna Performance Stock Units ("PSUs") granted under the Aetna Inc. 2010 Stock Incentive Plan (the "Plan") pursuant to the Merger Agreement and that vest on February 19, 2019; (2) 35,946 CVS Health RSUs that were converted from Aetna PSUs granted under the Plan pursuant to the Merger Agreement and that vest on February 17, 2020; and (3) 84,547 CVS Health RSUs that were converted from Aetna RSUs granted under the Plan pursuant to the Merger Agreement and that vest in three equal annual installments beginning on December 2, 2018. Read SEC document |
| November 28, 2018 Filed Nov 30, 2018 22:05 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 62,747 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-034855 · form4.xml · nonDerivative · entry 1 Lynch Karen S · CIK 0001333760 · EVP & Pres, Aetna Bus Unit 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,747 F1 · price: Pursuant to the terms of the Agreement and Plan of Merger, dated as of December 3, 2017 (the "Merger Agreement"), by and among CVS Health Corporation ("CVS Health"), Hudson Merger Sub Corp. (the "Merger Sub"), a wholly owned subsidiary of CVS Health, and Aetna Inc. ("Aetna"), on November 28, 2018 (the "Closing Date") the Merger Sub merged with and into Aetna (the "Merger"), with Aetna continuing as the surviving company of the Merger and as a wholly owned subsidiary of CVS Health. Pursuant to the Merger Agreement, on the Closing Date each share of Aetna common stock held by the reporting person was converted into the right to receive 0.8378 of a share of common stock of CVS Health and $145.00 in cash. The closing price of CVS Health's common stock on November 28, 2018 was $80.27 per share. Read SEC document |
| April 20, 2018 Filed Apr 23, 2018 20:20 UTC | US BANCORP DE USB · Entity 2923 | GrantDeferred Compensation Plan Participation · Derivative | 2,012 | $50.70 | $102,008.40 |
DisclosureSEC source: 0001225208-18-007965 · doc4.xml · derivative · entry 2 Lynch Karen S · CIK 0001333760 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,576 Underlying: Common Stock, $0.01 par value · 2,012 shares Expires not disclosed F3 · derivative.exercise_price: Deferred Compensation Plan Participation is payable in common stock when the reporting person ceases to serve on U.S. Bancorp's Board of Directors. F3 · derivative.exercise_date: Deferred Compensation Plan Participation is payable in common stock when the reporting person ceases to serve on U.S. Bancorp's Board of Directors. F3 · derivative.expiration_date: Deferred Compensation Plan Participation is payable in common stock when the reporting person ceases to serve on U.S. Bancorp's Board of Directors. F4 · balance_after: Includes amounts acquired pursuant to dividend reinvestment. Read SEC document |
| April 19, 2018 Filed Apr 23, 2018 20:20 UTC | US BANCORP DE USB · Entity 2923 | GrantRestricted Stock Units · Derivative | 2,959 | $50.70 | $150,021.30 |
DisclosureSEC source: 0001225208-18-007965 · doc4.xml · derivative · entry 1 Lynch Karen S · CIK 0001333760 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,959 Underlying: Common Stock, $0.01 par value · 2,959 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: The restricted stock units were fully vested at the time of grant. Units are payable in common stock when the reporting person ceases to serve on the Board of Directors and is not providing services to the Company as an independent contractor, except that all units are forfeited if the holder's service is terminated for cause. F2 · derivative.expiration_date: The restricted stock units were fully vested at the time of grant. Units are payable in common stock when the reporting person ceases to serve on the Board of Directors and is not providing services to the Company as an independent contractor, except that all units are forfeited if the holder's service is terminated for cause. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 16:15 UTC | AETNA INC /PA/ AET · Entity 107289 | GrantRestricted Stock Units · Derivative | 30,981 | $0.00 | $0.00 |
DisclosureSEC source: 0001122304-18-000032 · edgar.xml · derivative · entry 4 Lynch Karen S · CIK 0001333760 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,981 Underlying: Common Stock · 30,981 shares Expires not disclosed F5 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a right to receive one share of Aetna Inc. Common Stock net of taxes. F6 · derivative.exercise_date: RSUs granted under the Plan vest in three annual installments beginning December 2, 2018. F6 · derivative.expiration_date: RSUs granted under the Plan vest in three annual installments beginning December 2, 2018. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 16:15 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionPerformance Stock Units · Derivative | 14,926 | $0.00 | $0.00 |
DisclosureSEC source: 0001122304-18-000032 · edgar.xml · derivative · entry 3 Lynch Karen S · CIK 0001333760 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,926 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each PSU represents a right to receive up to two shares of Aetna Inc. Common Stock net of taxes. F4 · derivative.exercise_date: PSUs granted under the Plan. F4 · derivative.expiration_date: PSUs granted under the Plan. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 16:15 UTC | AETNA INC /PA/ AET · Entity 107289 | Tax withholdingCommon Stock | 7,277 | $177.53 | $1,291,885.81 |
DisclosureSEC source: 0001122304-18-000032 · edgar.xml · nonDerivative · entry 2 Lynch Karen S · CIK 0001333760 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,896 F3 · shares: Represents tax withholding on vesting of previously reported PSUs. Read SEC document |
| March 02, 2018 Filed Mar 6, 2018 16:15 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionCommon Stock | 17,912 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-18-000032 · edgar.xml · nonDerivative · entry 1 Lynch Karen S · CIK 0001333760 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,173 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of previously reported Performance Stock Units ("PSUs") granted under the 2010 Stock Incentive Plan (the "Plan"). F2 · price: Each PSU represents a right to receive up to two shares of Aetna Inc. Common Stock net of taxes. Read SEC document |
| January 26, 2018 Filed Jan 29, 2018 21:25 UTC | US BANCORP DE USB · Entity 2923 | GrantDeferred Compensation Plan Participation · Derivative | 561 | $57.98 | $32,526.78 |
DisclosureSEC source: 0001225208-18-001765 · doc4.xml · derivative · entry 1 Lynch Karen S · CIK 0001333760 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 561 Underlying: Common Stock, $0.01 par value · 561 shares Expires not disclosed F1 · derivative.exercise_price: Deferred Compensation Plan Participation is payable in common stock when the reporting person ceases to serve on U.S. Bancorp's Board of Directors. F1 · derivative.exercise_date: Deferred Compensation Plan Participation is payable in common stock when the reporting person ceases to serve on U.S. Bancorp's Board of Directors. F1 · derivative.expiration_date: Deferred Compensation Plan Participation is payable in common stock when the reporting person ceases to serve on U.S. Bancorp's Board of Directors. Read SEC document |
| January 18, 2018 Filed Jan 22, 2018 21:29 UTC | US BANCORP DE USB · Entity 2923 | GrantRestricted Stock Units · Derivative | 890 | $56.15 | $49,973.50 |
DisclosureSEC source: 0001225208-18-001342 · doc4.xml · derivative · entry 1 Lynch Karen S · CIK 0001333760 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 890 Underlying: Common Stock, $0.01 par value · 890 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: The restricted stock units were fully vested at the time of grant. Units are payable in common stock when the reporting person ceases to serve on the Board of Directors and is not providing services to the Company as an independent contractor, except that all units are forfeited if the holder's service is terminated for cause. F2 · derivative.expiration_date: The restricted stock units were fully vested at the time of grant. Units are payable in common stock when the reporting person ceases to serve on the Board of Directors and is not providing services to the Company as an independent contractor, except that all units are forfeited if the holder's service is terminated for cause. Read SEC document |
| December 19, 2017 Filed Dec 21, 2017 16:20 UTC | AETNA INC /PA/ AET · Entity 107289 | GrantPerformance Stock Units · Derivative | 14,926 | $0.00 | $0.00 |
DisclosureSEC source: 0001122304-17-000133 · edgar.xml · derivative · entry 1 Lynch Karen S · CIK 0001333760 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,926 Underlying: Common Stock · 14,926 shares Expires not disclosed F1 · derivative.exercise_price: Performance Stock Units ("PSUs") granted under the Aetna Inc. 2010 Stock Incentive Plan. Each PSU represents a right to receive up to two shares of Aetna Inc. Common Stock net taxes, depending on performance against the specified Company performance target. F2 · derivative.exercise_date: PSUs originally granted on March 2, 2015. Units vest based on both service through March 2, 2018 and attaining the specified Company performance target. On December 19, 2017, the Company's Committee on Compensation and Talent Management determined that the performance target had been met at a specified level for the performance period. Units will fully vest in accordance with the Plan if executive remains employed by the Company through March 2, 2018. F2 · derivative.expiration_date: PSUs originally granted on March 2, 2015. Units vest based on both service through March 2, 2018 and attaining the specified Company performance target. On December 19, 2017, the Company's Committee on Compensation and Talent Management determined that the performance target had been met at a specified level for the performance period. Units will fully vest in accordance with the Plan if executive remains employed by the Company through March 2, 2018. Read SEC document |
| September 18, 2017 Filed Sep 20, 2017 16:40 UTC | AETNA INC /PA/ AET · Entity 107289 | SaleCommon Stock | 15,271 | $161.91 | $2,472,526.08 |
DisclosureSEC source: 0001122304-17-000099 · edgar.xml · nonDerivative · entry 1 Lynch Karen S · CIK 0001333760 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,261 F1 · price: The price reported is average weighted share price. These shares were sold in multiple transactions at prices ranging from $161.62 to $162.0201, inclusive. Read SEC document |
| September 12, 2017 Filed Sep 14, 2017 16:45 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionStock Appreciation Rights · Derivative | 53,773 | $72.26 Strike: $72.26 | $3,885,636.98 |
DisclosureSEC source: 0001122304-17-000096 · edgar.xml · derivative · entry 3 Lynch Karen S · CIK 0001333760 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 53,773 shares Expires 2024-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2017 Filed Sep 14, 2017 16:45 UTC | AETNA INC /PA/ AET · Entity 107289 | Tax withholdingCommon Stock | 38,502 | $162.83 | $6,269,280.66 |
DisclosureSEC source: 0001122304-17-000096 · edgar.xml · nonDerivative · entry 2 Lynch Karen S · CIK 0001333760 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,532 F1 · price: Stock Appreciation Right is net settled; amount represents withholding of shares by the Company to pay exercise price and taxes. Read SEC document |
| September 12, 2017 Filed Sep 14, 2017 16:45 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionCommon Stock | 53,773 | $72.26 | $3,885,636.98 |
DisclosureSEC source: 0001122304-17-000096 · edgar.xml · nonDerivative · entry 1 Lynch Karen S · CIK 0001333760 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,034 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2017 Filed Jun 9, 2017 16:03 UTC | AETNA INC /PA/ AET · Entity 107289 | SaleCommon Stock | 7,825 | $149.72 | $1,171,550.39 |
DisclosureSEC source: 0001122304-17-000072 · edgar.xml · nonDerivative · entry 1 Lynch Karen S · CIK 0001333760 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,261 F1 · price: The price reported is average weighted share price. These shares were sold in multiple transactions at prices ranging from $149.44 to $149.93, inclusive. Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 16:26 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionStock Appreciation Rights · Derivative | 30,000 | $72.26 Strike: $72.26 | $2,167,800.00 |
DisclosureSEC source: 0001122304-17-000070 · edgar.xml · derivative · entry 3 Lynch Karen S · CIK 0001333760 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,773 Underlying: Common Stock · 30,000 shares Expires 2024-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 16:26 UTC | AETNA INC /PA/ AET · Entity 107289 | Tax withholdingCommon Stock | 22,175 | $147.73 | $3,275,912.75 |
DisclosureSEC source: 0001122304-17-000070 · edgar.xml · nonDerivative · entry 2 Lynch Karen S · CIK 0001333760 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,207 F1 · price: Stock Appreciation Right is net settled; amount represents withholding of shares by the Company to pay exercise price and taxes. Read SEC document |
| June 02, 2017 Filed Jun 6, 2017 16:26 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionCommon Stock | 30,000 | $72.26 | $2,167,800.00 |
DisclosureSEC source: 0001122304-17-000070 · edgar.xml · nonDerivative · entry 1 Lynch Karen S · CIK 0001333760 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,382 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 16:47 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionPerformance Stock Units · Derivative | 11,418 | $0.00 | $0.00 |
DisclosureSEC source: 0001122304-17-000025 · edgar.xml · derivative · entry 3 Lynch Karen S · CIK 0001333760 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,418 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Performance Stock Unit represents a right to receive up to two shares of Aetna Inc. Common Stock net of taxes. F4 · derivative.exercise_date: Performance Stock Units granted under the Plan. F4 · derivative.expiration_date: Performance Stock Units granted under the Plan. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 16:47 UTC | AETNA INC /PA/ AET · Entity 107289 | Tax withholdingCommon Stock | 8,708 | $130.69 | $1,138,048.52 |
DisclosureSEC source: 0001122304-17-000025 · edgar.xml · nonDerivative · entry 2 Lynch Karen S · CIK 0001333760 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,382 F3 · shares: Represents tax withholding on vesting of previously reported Performance Stock Units. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 16:47 UTC | AETNA INC /PA/ AET · Entity 107289 | Exercise / conversionCommon Stock | 22,836 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001122304-17-000025 · edgar.xml · nonDerivative · entry 1 Lynch Karen S · CIK 0001333760 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,090 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of previously reported Performance Stock Units granted under the 2010 Stock Incentive Plan (the "Plan"). F2 · price: Each Performance Stock Unit represents a right to receive up to two shares of Aetna Inc. Common Stock net of taxes. Read SEC document |
| March 03, 2017 Filed Jun 9, 2017 16:05 UTC Amendment | AETNA INC /PA/ AET · Entity 107289 | Tax withholdingCommon Stock | 9,829 | $130.69 | $1,284,552.01 |
DisclosureSEC source: 0001122304-17-000073 · edgar.xml · nonDerivative · entry 1 Lynch Karen S · CIK 0001333760 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,261 F1 · shares: Corrected the amount of tax withholding previously reported on vesting of Performance Stock Units. F2 · balance_after: Corresponding correction to amount of beneficially owned shares. Read SEC document |
| February 17, 2017 Filed Feb 22, 2017 16:29 UTC | AETNA INC /PA/ AET · Entity 107289 | GrantStock Appreciation Rights · Derivative | 105,941 | $0.00 Strike: $125.27 | $0.00 |
DisclosureSEC source: 0001231553-17-000004 · edgar.xml · derivative · entry 1 Lynch Karen S · CIK 0001333760 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,941 Underlying: Common Stock · 105,941 shares Expires 2027-02-17 F1 · derivative.exercise_date: Stock Appreciation Rights granted under the Aetna Inc. 2010 Stock Incentive Plan, exercisable in three annual installments beginning February 17, 2018. F1 · derivative.expiration_date: Stock Appreciation Rights granted under the Aetna Inc. 2010 Stock Incentive Plan, exercisable in three annual installments beginning February 17, 2018. Read SEC document |
| January 19, 2017 Filed Jan 23, 2017 21:25 UTC | US BANCORP DE USB · Entity 2923 | GrantRestricted Stock Units · Derivative | 2,957 | $50.73 | $150,008.61 |
DisclosureSEC source: 0001225208-17-001461 · doc4.xml · derivative · entry 1 Lynch Karen S · CIK 0001333760 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,957 Underlying: Common Stock, $0.01 par value · 2,957 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: The restricted stock units were fully vested at the time of grant. Units are payable in common stock when the reporting person ceases to serve on the Board of Directors and is not providing services to the Company as an independent contractor, except that all units are forfeited if the holder's service is terminated for cause. F2 · derivative.expiration_date: The restricted stock units were fully vested at the time of grant. Units are payable in common stock when the reporting person ceases to serve on the Board of Directors and is not providing services to the Company as an independent contractor, except that all units are forfeited if the holder's service is terminated for cause. Read SEC document |
| November 11, 2016 Filed Nov 15, 2016 16:06 UTC | AETNA INC /PA/ AET · Entity 107289 | SaleCommon Stock | 45,000 | $119.55 | $5,379,925.50 |
DisclosureSEC source: 0001122304-16-000295 · edgar.xml · nonDerivative · entry 1 Lynch Karen S · CIK 0001333760 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,254 F1 · price: The price reported is average weighted share price. These shares were sold in multiple transactions at prices ranging from $119.42 to $119.75, inclusive. F2 · balance_after: Number of aggregate shares beneficially owned corrected. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.